Local signals with global impacts and clinical implications: Lessons from the plasma membrane calcium pump (PMCA4)

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 5, 2011, Pages 974-978

  Oceandy, Delvac ^a   Mohamed, Tamer M A ^a   Cartwright, Elizabeth J ^a   Neyses, Ludwig ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Calcium; Contractility; Hypertrophy; Interaction; PMCA; Signalling

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

CALCIUM SIGNALING; HEART MUSCLE CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 79955658516     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.12.007     Document Type: Review

References (42)

1. Bers D.M. Calcium fluxes involved in control of cardiac myocyte contraction. Circ. Res. 2000, 87:275-281.
2. Brini M., Carafoli E. Calcium pumps in health and disease. Physiol. Rev. 2009, 89:1341-1378.
3. Frey N., McKinsey T.A., Olson E.N. Decoding calcium signals involved in cardiac growth and function. Nat. Med. 2000, 6:1221-1227.
4. Strehler E.E., Zacharias D.A. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol. Rev. 2001, 81:21-50.
5. Fujimoto T. Calcium pump of the plasma membrane is localized in caveolae. J. Cell Biol. 1993, 120:1147-1157.
6. Hammes A., Oberdorf-Maass S., Rother T., Nething K., Gollnick F., Linz K.W., Meyer R., Hu K., Han H., Gaudron P., Ertl G., Hoffmann S., Ganten U., Vetter R., Schuh K., Benkwitz C., Zimmer H.G., Neyses L. Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats. Circ. Res. 1998, 83:877-888.
7. Parton R.G. Cell biology. Life without caveolae. Science 2001, 293:2404-2405.
8. Oceandy D., Stanley P.J., Cartwright E.J., Neyses L. The regulatory function of plasma-membrane Ca(2+)-ATPase (PMCA) in the heart. Biochem. Soc. Trans. 2007, 35:927-930.
9. Cho K.O., Hunt C.A., Kennedy M.B. The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron 1992, 9:929-942.
10. Woods D.F., Bryant P.J. The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions. Cell 1991, 66:451-464.
11. Itoh M., Nagafuchi A., Yonemura S., Kitani-Yasuda T., Tsukita S., Tsukita S. The 220-kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction-associated protein in epithelial cells: cDNA cloning and immunoelectron microscopy. J. Cell Biol. 1993, 121:491-502.
12. Fanning A.S., Anderson J.M. PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J. Clin. Invest. 1999, 103:767-772.
13. Ponting C.P., Phillips C., Davies K.E., Blake D.J. PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays 1997, 19:469-479.
14. Dev K.K. Making protein interactions druggable: targeting PDZ domains. Nat. Rev. Drug Discov. 2004, 3:1047-1056.
15. Hillier B.J., Christopherson K.S., Prehoda K.E., Bredt D.S., Lim W.A. Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science 1999, 284:812-815.
16. Songyang Z., Fanning A.S., Fu C., Xu J., Marfatia S.M., Chishti A.H., Crompton A., Chan A.C., Anderson J.M., Cantley L.C. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 1997, 275:73-77.
17. Kim E., DeMarco S.J., Marfatia S.M., Chishti A.H., Sheng M., Strehler E.E. Plasma membrane Ca2+ ATPase isoform 4b binds to membrane-associated guanylate kinase (MAGUK) proteins via their PDZ (PSD-95/Dlg/ZO-1) domains. J. Biol. Chem. 1998, 273:1591-1595.
18. Schuh K., Uldrijan S., Telkamp M., Rothlein N., Neyses L. The plasma membrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I. J. Cell Biol. 2001, 155:201-205.
19. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 2001, 357:593-615.
20. Schuh K., Uldrijan S., Gambaryan S., Roethlein N., Neyses L. Interaction of the plasma membrane Ca2+ pump 4b/CI with the Ca2+/calmodulin-dependent membrane-associated kinase CASK. J. Biol. Chem. 2003, 278:9778-9783.
21. Goellner G.M., DeMarco S.J., Strehler E.E. Characterization of PISP, a novel single-PDZ protein that binds to all plasma membrane Ca2+-ATPase b-splice variants. Ann. NY Acad. Sci. 2003, 986:461-471.
22. Sgambato-Faure V., Xiong Y., Berke J.D., Hyman S.E., Strehler E.E. The Homer-1 protein Ania-3 interacts with the plasma membrane calcium pump. Biochem. Biophys. Res. Commun. 2006, 343:630-637.
23. Bozulic L.D., Malik M.T., Powell D.W., Nanez A., Link A.J., Ramos K.S., Dean W.L. Plasma membrane Ca(2+) -ATPase associates with CLP36, alpha-actinin and actin in human platelets. Thromb. Haemost. 2007, 97:587-597.
24. James P., Maeda M., Fischer R., Verma A.K., Krebs J., Penniston J.T., Carafoli E. Identification and primary structure of a calmodulin binding domain of the Ca2+ pump of human erythrocytes. J. Biol. Chem. 1988, 263:2905-2910.
25. Falchetto R., Vorherr T., Carafoli E. The calmodulin-binding site of the plasma membrane Ca2+ pump interacts with the transduction domain of the enzyme. Protein Sci. 1992, 1:1613-1621.
26. Carafoli E. Biogenesis: plasma membrane calcium ATPase: 15 years of work on the purified enzyme. FASEB J. 1994, 8:993-1002.
27. Armesilla A.L., Williams J.C., Buch M.H., Pickard A., Emerson M., Cartwright E.J., Oceandy D., Vos M.D., Gillies S., Clark G.J., Neyses L. Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1. J. Biol. Chem. 2004, 279:31318-31328.
28. Williams J.C., Armesilla A.L., Mohamed T.M., Hagarty C.L., McIntyre F.H., Schomburg S., Zaki A.O., Oceandy D., Cartwright E.J., Buch M.H., Emerson M., Neyses L. The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex. J. Biol. Chem. 2006, 281:23341-23348.
29. Buch M.H., Pickard A., Rodriguez A., Gillies S., Maass A.H., Emerson M., Cartwright E.J., Williams J.C., Oceandy D., Redondo J.M., Neyses L., Armesilla A.L. The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. J. Biol. Chem. 2005, 280:29479-29487.
30. Rimessi A., Coletto L., Pinton P., Rizzuto R., Brini M., Carafoli E. Inhibitory interaction of the 14-3-3{epsilon} protein with isoform 4 of the plasma membrane Ca(2+)-ATPase pump. J. Biol. Chem. 2005, 280:37195-37203.
31. Linde C.I., Di Leva F., Domi T., Tosatto S.C., Brini M., Carafoli E. Inhibitory interaction of the 14-3-3 proteins with ubiquitous (PMCA1) and tissue-specific (PMCA3) isoforms of the plasma membrane Ca2+ pump. Cell Calcium 2008, 43:550-561.
32. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
33. Molkentin J.D. Dichotomy of Ca2+ in the heart: contraction versus intracellular signaling. J. Clin. Invest. 2006, 116:623-626.
34. Oceandy D., Cartwright E.J., Emerson M., Prehar S., Baudoin F.M., Zi M., Alatwi N., Venetucci L., Schuh K., Williams J.C., Armesilla A.L., Neyses L. Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b. Circulation 2007, 115:483-492.
35. Wu X., Chang B., Blair N.S., Sargent M., York A.J., Robbins J., Shull G.E., Molkentin J.D. Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents. J. Clin. Invest. 2009, 119:976-985.
36. Mohamed T.M., Oceandy D., Prehar S., Alatwi N., Hegab Z., Baudoin F.M., Pickard A., Zaki A.O., Nadif R., Cartwright E.J., Neyses L. Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium. J. Biol. Chem. 2009, 284:12091-12098.
37. Ueda K., Valdivia C., Medeiros-Domingo A., Tester D.J., Vatta M., Farrugia G., Ackerman M.J., Makielski J.C. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc. Natl Acad. Sci. USA 2008, 105:9355-9360.
38. Arking D.E., Pfeufer A., Post W., Kao W.H., Newton-Cheh C., Ikeda M., West K., Kashuk C., Akyol M., Perz S., Jalilzadeh S., Illig T., Gieger C., Guo C.Y., Larson M.G., Wichmann H.E., Marban E., O'Donnell C.J., Hirschhorn J.N., Kaab S., Spooner P.M., Meitinger T., Chakravarti A. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat. Genet. 2006, 38:644-651.
39. Beigi F., Oskouei B.N., Zheng M., Cooke C.A., Lamirault G., Hare J.M. Cardiac nitric oxide synthase-1 localization within the cardiomyocyte is accompanied by the adaptor protein, CAPON. Nitric Oxide 2009, 21:226-233.
40. Chang K.C., Barth A.S., Sasano T., Kizana E., Kashiwakura Y., Zhang Y., Foster D.B., Marban E. CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart. Proc. Natl Acad. Sci. USA 2008, 105:4477-4482.
41. Oceandy D., Pickard A., Prehar S., Zi M., Mohamed T.M., Stanley P.J., Baudoin-Stanley F., Nadif R., Tommasi S., Pfeifer G.P., Armesilla A.L., Cartwright E.J., Neyses L. Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy. Circulation 2009, 120:607-616.
42. Kotlikoff M.I. Genetically encoded Ca2+ indicators: using genetics and molecular design to understand complex physiology. J. Physiol. 2007, 578:55-67.